For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University of Nottingham

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial

Type
D - Journal article
Title of journal
Lancet
Article number
-
Volume number
375
Issue number
9715
First page of article
641
ISSN of journal
0140-6736
Year of publication
2010
Number of additional authors
13
Additional information

a. The author made a substantial contribution to the organisation of the conduct of the study, to carrying out the study (including acquisition of study data);and to analysis and interpretation of study data.

and

b. The author helped critique the output for important intellectual content

Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
36
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-